SNRPB2: a prognostic biomarker and oncogenic driver in esophageal cancer via β-catenin/c-Myc signaling
Our findings demonstrate that SNRPB2 contributes to ESCA progression by regulating the β-catenin/c-Myc axis, suggesting its potential as a prognostic biomarker and therapeutic target for ESCA patients.
Authors
- Jiaqian Bao
- Xiong Tian (ORCID: https://orcid.org/0000-0002-8354-8447)
- Yixiao Pan
- Zhenyu Yang (ORCID: https://orcid.org/0000-0003-3163-7998)
- Jingmin Zheng
- Yiqing Guo (ORCID: https://orcid.org/0009-0007-3133-4619)
- Meifu Gan (ORCID: https://orcid.org/0000-0002-8143-100X)
Institutions
- Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-15
- DOI
- https://doi.org/10.3389/fonc.2025.1536473
- Citations
- 1
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 0.81